NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 3 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,845,000 | -21.5% | 40,600 | -31.6% | 0.00% | -33.3% |
| Q1 2016 | $2,349,000 | -26.4% | 59,400 | +5.3% | 0.00% | 0.0% |
| Q4 2015 | $3,191,000 | +5.5% | 56,400 | -25.8% | 0.00% | 0.0% |
| Q3 2015 | $3,024,000 | -15.0% | 76,000 | +2.0% | 0.00% | 0.0% |
| Q2 2015 | $3,558,000 | +46.2% | 74,500 | +21.5% | 0.00% | +50.0% |
| Q1 2015 | $2,434,000 | +34.2% | 61,300 | -24.5% | 0.00% | 0.0% |
| Q4 2014 | $1,814,000 | +92.6% | 81,200 | +35.1% | 0.00% | +100.0% |
| Q3 2014 | $942,000 | +126.4% | 60,100 | +114.6% | 0.00% | – |
| Q2 2014 | $416,000 | +0.5% | 28,000 | +8.9% | 0.00% | – |
| Q1 2014 | $414,000 | +146.4% | 25,700 | +42.8% | 0.00% | – |
| Q4 2013 | $168,000 | -69.8% | 18,000 | -63.4% | 0.00% | -100.0% |
| Q3 2013 | $557,000 | +112.6% | 49,200 | +151.0% | 0.00% | – |
| Q2 2013 | $262,000 | – | 19,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 25 | $240,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 31,300 | $3,000,000 | 0.01% |
| SIMPLEX TRADING, LLC | 235 | $2,252,000 | 0.00% |
| Interchange Capital Partners, LLC | 2 | $1,000 | 0.00% |
| JPMORGAN CHASE & CO | 41,800 | $4,007,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |